InMode Appoints Michael Dennison as President of North America

Core Insights - InMode Ltd. has appointed Michael Dennison as President of North America, highlighting his extensive experience in the aesthetic medical device industry and his previous leadership roles within the company [1][2]. Company Overview - InMode is a leading global provider of innovative medical technologies, specializing in devices that utilize novel radiofrequency (RF) technology for various medical applications, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology [3]. Leadership and Strategy - Michael Dennison's promotion is seen as a strategic move to enhance InMode's market presence and drive growth in North America, with a focus on cultivating talent and achieving market excellence [2]. - Dennison aims to build on InMode's strong foundation and accelerate momentum in the North American market, delivering greater value to partners and setting new industry standards [2]. Financial Performance - InMode expects to report third-quarter 2025 revenue between $92.5 million and $93.0 million, reiterating its full-year 2025 guidance of $365 million to $375 million [5].